Health Care Rose on Defensive Bias -- Health Care Roundup

Health-care companies rose sharply as traders rotated into sectors less affected by economic cycles.

A U.S. judge dismissed a series of lawsuits around GSK and Sanofi's jointly marketed Zantac heartburn medication.

Syndax Pharmaceuticals shares fell after a follow-on offering.

 Write to Rob Curran at [e-mail] 

(END) Dow Jones Newswires

12-07-22 1713ET